Agency Information Collection Activities; Proposed Collection; Comments Requested: Application for Individual Manufacturing Quota for a Basic Class of Controlled Substance and for Ephedrine, Pseudoephedrine, and Phenylpropanolamine, 9428-9429 [2013-02876]

Download as PDF 9428 Federal Register / Vol. 78, No. 27 / Friday, February 8, 2013 / Notices DEPARTMENT OF JUSTICE [OMB Number 1105–NEW] Agency Information Collection Activities; Proposed Collection; Comments Requested: Claims of U.S. Nationals for Compensation for Serious Personal Injuries Against the Government of Iraq and Referred to the Foreign Claims Settlement Commission by the Department of State Legal Adviser sroberts on DSK5SPTVN1PROD with NOTICES ACTION: 30-day notice. The Foreign Claims Settlement Commission (Commission), an independent agency organized within the Department of Justice, will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. This proposed information collection was previously published in the Federal Register Volume 77, Number 236, pages 73051–73052 on December 7, 2012, allowing for a 60 day comment period. The purpose of this notice is to allow for an additional 30 days for public comment March 11, 2013. This process is conducted in accordance with 5 CFR 1320.10. Written comments and/or suggestions regarding the items contained in this notice, especially the estimated public burden and associated response time, should be directed to the Office of Management and Budget, Office of Information and Regulatory Affairs, Attention Department of Justice Desk Officer, Washington, DC 20503. Additionally, comments may be submitted to OMB via facsimile to (202) 395–5806. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; —Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Enhance the quality, utility, and clarity of the information to be collected; and VerDate Mar<15>2010 17:23 Feb 07, 2013 Jkt 229001 —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Overview of This Information Collection (1) Type of Information Collection: New collection. (2) The title of the form/collection: Claims of U.S. Nationals Against Iraq. (3) The agency form number, if any, and the applicable component of the department sponsoring the collection: Form Number: FCSC 1–12. Foreign Claims Settlement Commission, Department of Justice. (4) Effected public who will be asked or required to respond, as well as a brief abstract: Primary: Individuals. Other: None. Information will be used as a basis to adjudicate eligibility for compensation of U.S. nationals, under the U.S.-Iraq Claims Settlement Agreement and the November 14, 2012 referral to the Commission by the Department of State Legal Adviser, for serious personal injuries, which may include instances of serious physical, mental, or emotional injury arising from sexual assault, coercive interrogation, mock execution, or aggravated physical assault. Awards will be payable by the Department of the Treasury out of funds provided. (5) An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond/reply: It is estimated that 20 individual respondents will complete the application in approximately two hours each. (6) An estimate of the total public burden (in hours) associated with the collection: The estimated total annual public burden associated with this application is 40 hours. If additional information is required contact: Jerri Murray, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Two Constitution Square, 145 N Street NE., Room 3W– 1407B, Washington, DC 20530. Dated: February 5, 2013. Jerri Murray, Department Clearance Officer for PRA, U.S. Department of Justice. [FR Doc. 2013–02874 Filed 2–7–13; 8:45 am] BILLING CODE 4410–BA–P PO 00000 Frm 00072 Fmt 4703 Sfmt 4703 DEPARTMENT OF JUSTICE Drug Enforcement Administration [OMB Number 1117–0006] Agency Information Collection Activities; Proposed Collection; Comments Requested: Application for Individual Manufacturing Quota for a Basic Class of Controlled Substance and for Ephedrine, Pseudoephedrine, and Phenylpropanolamine ACTION: 30-day notice. The Department of Justice (DOJ), Drug Enforcement Administration (DEA) will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. This proposed information collection was previously published in the Federal Register Volume 77, Number 233, page 71831 on December 4, 2012, allowing for a 60 day comment period. The purpose of this notice is to allow for an additional 30 days for public comment until March 11, 2013. This process is conducted in accordance with 5 CFR 1320.10. Written comments and/ or suggestions regarding the items contained in this notice, especially the estimated public burden and associated response time, should be directed to the Office of Management and Budget, Office of Information and Regulatory Affairs, Attention Department of Justice Desk Officer, Washington, DC 20503. Additionally, comments may be submitted to OMB via facsimile to (202) 395–7285. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: • Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; • Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; • Enhance the quality, utility, and clarity of the information to be collected; and • Minimize the burden of the collection of information on those who are to respond, including through the E:\FR\FM\08FEN1.SGM 08FEN1 Federal Register / Vol. 78, No. 27 / Friday, February 8, 2013 / Notices use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. sroberts on DSK5SPTVN1PROD with NOTICES Overview of This Information Collection 1117–0006 17:23 Feb 07, 2013 Jkt 229001 [FR Doc. 2013–02876 Filed 2–7–13; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE (1) Type of Information Collection: Extension of a currently approved collection. (2) Title of the Form/Collection: Application for Individual Manufacturing Quota for a Basic Class of Controlled Substance and for Ephedrine, Pseudoephedrine, and Phenylpropanolamine (DEA Form 189). (3) Agency form number, if any, and the applicable component of the Department of Justice sponsoring the collection: Form Number: DEA Form 189, Office of Diversion Control, Drug Enforcement Administration, Department of Justice. (4) Affected public who will be asked or required to respond, as well as a brief abstract: Primary: Business or other forprofit. Other: None. Abstract: 21 U.S.C. 826 and 21 CFR 1303.22 and 1315.22 require that any person who is registered to manufacture any basic class of controlled substances listed in Schedule I or II and who desires to manufacture a quantity of such class, or who desires to manufacture using the List I chemicals ephedrine, pseudoephedrine, or phenylpropanolamine, must apply on DEA Form 189 for a manufacturing quota for such quantity of such class or List I chemical. (5) An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: DEA estimates that each form takes 0.5 hours (30 minutes) to complete. In total, 33 firms submit 641 responses, with each response taking 0.5 hours (30 minutes) to complete. This results in a total public burden of 320.5 hours annually. (6) An estimate of the total public burden (in hours) associated with the collection: In total, 33 firms submit 641 responses, with each response taking 0.5 hours (30 minutes) to complete. This results in a total public burden of 320.5 hours annually. If additional information is required contact: Jerri Murray, Department Clearance Officer, Policy and Planning Staff, Justice Management Division, Department of Justice, Two Constitution Square, 145 N Street, NE., Room 3W– 1407B, Washington, DC 20530. VerDate Mar<15>2010 Dated: February 5, 2013. Jerri Murray, Department Clearance Officer, PRA, United States Department of Justice. Drug Enforcement Administration [OMB Number 1117–0008] Agency Information Collection Activities; Proposed Collection; Comments Requested: Application for Procurement Quota for Controlled Substances and Ephedrine, Pseudoephedrine, and Phenylpropanolamine ACTION: 30-day notice. The Department of Justice (DOJ), Drug Enforcement Administration (DEA) will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. This proposed information collection was previously published in the Federal Register Volume 77, Number 233, page 71832 on December 4, 2012, allowing for a 60 day comment period. The purpose of this notice is to allow for an additional 30 days for public comment until March 11, 2013. This process is conducted in accordance with 5 CFR 1320.10. Written comments and/or suggestions regarding the items contained in this notice, especially the estimated public burden and associated response time, should be directed to the Office of Management and Budget, Office of Information and Regulatory Affairs, Attention Department of Justice Desk Officer, Washington, DC 20503. Additionally, comments may be submitted to OMB via facsimile to (202) 395–7285. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: • Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; • Evaluate the accuracy of the agencies estimate of the burden of the PO 00000 Frm 00073 Fmt 4703 Sfmt 4703 9429 proposed collection of information, including the validity of the methodology and assumptions used; • Enhance the quality, utility, and clarity of the information to be collected; and • Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Overview of This Information Collection 1117–0008 (1) Type of Information Collection: Extension of a currently approved collection. (2) Title of the Form/Collection: Application for Procurement Quota for Controlled Substances and Ephedrine, Pseudoephedrine, and Phenylpropanolamine (DEA Form 250). (3) Agency form number, if any, and the applicable component of the Department sponsoring the collection: DEA Form 250, Office of Diversion Control, Drug Enforcement Administration, Department of Justice. (4) Affected public who will be asked or required to respond, as well as a brief abstract: Primary: Business or other for-profit. Other: None. Abstract: 21 U.S.C. 826 and 21 CFR 1303.12 and 1315.32 require that U.S. companies who desire to use any basic class of controlled substances listed in Schedule I or II or the List I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine for purposes of manufacturing during the next calendar year shall apply on DEA Form 250 for procurement quota for such class or List I chemical. (5) An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: DEA estimates that each form takes 1⁄2 hour to complete. DEA estimates that 419 individual respondents will respond to this form. DEA estimates that 2,716 responses are received annually. (6) An estimate of the total public burden (in hours) associated with the collection: The total public burden for this collection is 1,358 hours annually. If additional information is required contact: Jerri Murray, Department Clearance Officer, Policy and Planning Staff, Justice Management Division, Department of Justice, Two Constitution Square, 145 N Street NE., Room 3W– 1407B, Washington, DC 20530. E:\FR\FM\08FEN1.SGM 08FEN1

Agencies

[Federal Register Volume 78, Number 27 (Friday, February 8, 2013)]
[Notices]
[Pages 9428-9429]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-02876]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[OMB Number 1117-0006]


Agency Information Collection Activities; Proposed Collection; 
Comments Requested: Application for Individual Manufacturing Quota for 
a Basic Class of Controlled Substance and for Ephedrine, 
Pseudoephedrine, and Phenylpropanolamine

ACTION: 30-day notice.

-----------------------------------------------------------------------

    The Department of Justice (DOJ), Drug Enforcement Administration 
(DEA) will be submitting the following information collection request 
to the Office of Management and Budget (OMB) for review and approval in 
accordance with the Paperwork Reduction Act of 1995. The proposed 
information collection is published to obtain comments from the public 
and affected agencies. This proposed information collection was 
previously published in the Federal Register Volume 77, Number 233, 
page 71831 on December 4, 2012, allowing for a 60 day comment period.
    The purpose of this notice is to allow for an additional 30 days 
for public comment until March 11, 2013. This process is conducted in 
accordance with 5 CFR 1320.10. Written comments and/or suggestions 
regarding the items contained in this notice, especially the estimated 
public burden and associated response time, should be directed to the 
Office of Management and Budget, Office of Information and Regulatory 
Affairs, Attention Department of Justice Desk Officer, Washington, DC 
20503. Additionally, comments may be submitted to OMB via facsimile to 
(202) 395-7285.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address one or more of the following 
four points:
     Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
     Evaluate the accuracy of the agencies estimate of the 
burden of the proposed collection of information, including the 
validity of the methodology and assumptions used;
     Enhance the quality, utility, and clarity of the 
information to be collected; and
     Minimize the burden of the collection of information on 
those who are to respond, including through the

[[Page 9429]]

use of appropriate automated, electronic, mechanical, or other 
technological collection techniques or other forms of information 
technology, e.g., permitting electronic submission of responses.

Overview of This Information Collection 1117-0006

    (1) Type of Information Collection: Extension of a currently 
approved collection.
    (2) Title of the Form/Collection: Application for Individual 
Manufacturing Quota for a Basic Class of Controlled Substance and for 
Ephedrine, Pseudoephedrine, and Phenylpropanolamine (DEA Form 189).
    (3) Agency form number, if any, and the applicable component of the 
Department of Justice sponsoring the collection: Form Number: DEA Form 
189, Office of Diversion Control, Drug Enforcement Administration, 
Department of Justice.
    (4) Affected public who will be asked or required to respond, as 
well as a brief abstract: Primary: Business or other for-profit.
    Other: None.
    Abstract: 21 U.S.C. 826 and 21 CFR 1303.22 and 1315.22 require that 
any person who is registered to manufacture any basic class of 
controlled substances listed in Schedule I or II and who desires to 
manufacture a quantity of such class, or who desires to manufacture 
using the List I chemicals ephedrine, pseudoephedrine, or 
phenylpropanolamine, must apply on DEA Form 189 for a manufacturing 
quota for such quantity of such class or List I chemical.
    (5) An estimate of the total number of respondents and the amount 
of time estimated for an average respondent to respond: DEA estimates 
that each form takes 0.5 hours (30 minutes) to complete. In total, 33 
firms submit 641 responses, with each response taking 0.5 hours (30 
minutes) to complete. This results in a total public burden of 320.5 
hours annually.
    (6) An estimate of the total public burden (in hours) associated 
with the collection: In total, 33 firms submit 641 responses, with each 
response taking 0.5 hours (30 minutes) to complete. This results in a 
total public burden of 320.5 hours annually.
    If additional information is required contact: Jerri Murray, 
Department Clearance Officer, Policy and Planning Staff, Justice 
Management Division, Department of Justice, Two Constitution Square, 
145 N Street, NE., Room 3W-1407B, Washington, DC 20530.

    Dated: February 5, 2013.
Jerri Murray,
Department Clearance Officer, PRA, United States Department of Justice.
[FR Doc. 2013-02876 Filed 2-7-13; 8:45 am]
BILLING CODE 4410-09-P